Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,407,000 | 7,211,000 | 5,117,000 | 3,801,000 | 9,658,000 |
| Marketable Securities | 15,922,000 | 951,000 | 239,000 | 276,000 | 1,905,000 |
| Receivables | 8,283,000 | 8,632,000 | 8,654,000 | 8,481,000 | 8,456,000 |
| Inventories | 6,666,000 | 6,885,000 | 7,111,000 | 6,997,000 | 7,131,000 |
| Other current assets | 2,440,000 | 2,574,000 | 2,687,000 | 2,643,000 | 2,523,000 |
| TOTAL | $45,718,000 | $26,253,000 | $23,808,000 | $22,198,000 | $29,673,000 |
| Non-Current Assets | |||||
| PPE Net | 11,545,000 | 11,602,000 | 11,738,000 | 11,603,000 | 12,263,000 |
| Investments And Advances | 3,241,000 | 12,347,000 | 12,014,000 | 11,628,000 | 12,533,000 |
| Intangibles | 63,777,000 | 63,523,000 | 64,584,000 | 64,967,000 | 66,808,000 |
| Other Non-Current Assets | 7,514,000 | 7,484,000 | 11,871,000 | 11,356,000 | 6,501,000 |
| TOTAL | $86,077,000 | $94,956,000 | $100,207,000 | $99,554,000 | $98,105,000 |
| Total Assets | $131,795,000 | $121,209,000 | $124,015,000 | $121,752,000 | $127,778,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,295,000 | 9,337,000 | 9,075,000 | 10,165,000 | 9,785,000 |
| Accounts payable and accrued liabilities | 5,553,000 | 4,665,000 | 4,811,000 | 5,040,000 | 5,403,000 |
| Other current liabilities | 15,670,000 | 13,138,000 | 13,097,000 | 12,442,000 | 15,127,000 |
| TOTAL | $30,208,000 | $29,880,000 | $29,633,000 | $30,160,000 | $33,059,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,902,000 | 23,101,000 | 24,828,000 | 25,747,000 | 26,259,000 |
| Other Non-Current Liabilities | 7,795,000 | 7,942,000 | 7,955,000 | 7,863,000 | 8,648,000 |
| TOTAL | $33,765,000 | $34,392,000 | $40,254,000 | $41,003,000 | $38,053,000 |
| Total Liabilities | $63,973,000 | $64,272,000 | $69,887,000 | $71,163,000 | $71,112,000 |
| Shareholders' Equity | |||||
| Common Shares | 901,000 | 901,000 | 913,000 | 913,000 | 913,000 |
| Retained earnings | 66,802,000 | 55,917,000 | 53,194,000 | 49,670,000 | 55,738,000 |
| Other shareholders' equity | 167,000 | 166,000 | 86,000 | 66,000 | 68,000 |
| TOTAL | $67,822,000 | $56,937,000 | $54,128,000 | $50,589,000 | $56,666,000 |
| Total Liabilities And Equity | $131,795,000 | $121,209,000 | $124,015,000 | $121,752,000 | $127,778,000 |